Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Atomo Diagnostics Ltd. ( (AU:AT1) ) is now available.
Atomo Diagnostics Ltd. has announced the quotation of 16,810,814 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AT1, effective from July 24, 2025. This move is part of a transaction previously disclosed to the market, and it is expected to enhance the company’s liquidity and provide additional capital for its operations, potentially strengthening its market position in the diagnostics sector.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and commercialization of rapid diagnostic test devices. The company is known for its innovative point-of-care testing solutions, which are designed to be user-friendly and accessible, catering to both healthcare professionals and consumers.
Average Trading Volume: 958,058
Technical Sentiment Signal: Hold
Current Market Cap: A$14.65M
See more data about AT1 stock on TipRanks’ Stock Analysis page.